BIOMARK DIAGNOSTICS INC.BIOMARK DIAGNOSTICS INC.BIOMARK DIAGNOSTICS INC.

BIOMARK DIAGNOSTICS INC.

No trades
See on Supercharts

BUX fundamentals

BIOMARK DIAGNOSTICS INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of BUX for the last quarter is 41.54 k CAD, and it's 1.38% lower compared to the previous quarter. The net income of Q3 23 is -406.76 k CAD.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CAD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth